Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BLADE-PCI Trial (Phase IIB Liposomal Alendronate Study)
2015-005445-32Phase 2Unknown
- Sponsor
- BioRest
- Start
- Mar 2016
- Modality
- Small Molecules, Lipid-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 2, randomised trial in coronary arteriosclerosis and type 2 diabetes mellitus (T2DM) comparing LABR-312 liposomal alendronate with Placebo (2 arms). Status: unknown.
02
Drugs
Liposomal alendronate
03
Conditions
coronary arteriosclerosistype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on 2015-005445-32.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2015-005445-32.